Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Lumbar WBCT vs MRI

10 de noviembre de 2026 actualizado por: Neil Segal, MD, MS, University of Kansas Medical Center

Standing Weight-Bearing Cone-Beam CT and Clinical Phenotype Concordance in Lumbar Degenerative Radiculopathy

Patients with pain in their low back that sometimes sends a shooting, sharp pain down their leg are usually diagnosed with lumbar radicular pain, or lumbar radiculopathy. MRIs are most commonly used to acquire images of the spine. The purpose of these images is to provide doctors with important information on what may be causing the low back pain and what treatment options may be the most effective in treating the pain. However, standard MRIs are taken when the patient is lying down, which may not be the most accurate representation of what the spine looks like in positions where patients experience pain, such as standing. A weight-bearing CT (WBCT) scan is a 3D imaging test that takes detailed pictures of the spine while patients are standing up. Unlike traditional MRI scans, where the patient lies down, this technology provides more information on how the spine looks when the patient is upright and participating in activities such as standing and walking. This information allows doctors to better understand the underlying causes of the pain and help guide targeted treatments to address those issues.

The Planmed XFI full-body weight-bearing CT scanner received 510(k) clearance from the FDA on September 26, 2025. This means the Planmed XFI® WBCT is safe and effective because it is substantially equivalent to a device already on the market.

Descripción general del estudio

Estado

Aún no reclutando

Intervención / Tratamiento

Descripción detallada

Lumbar radicular pain and radiculopathy arise from heterogeneous mechanical and inflammatory processes affecting the lumbar nerve roots. Accurate localization of the symptomatic root determines the target of interventional and surgical treatment, and incorrect localization is a plausible contributor to procedural non-response. MRI is the principal imaging examination for suspected radiculopathy because it depicts the discs, nerve roots, and perineural fat. Its agreement with the clinically symptomatic root, however, is moderate at best. For the present study, a prospectively standardized, blinded, pre-imaging clinical phenotype serves as the operational reference standard. It is performed in every participant before any study imaging, locked before acquisition, and not revised afterward, so that imaging is scored against a fixed clinical target rather than reconciled with it. Across loaded and upright studies, mean positional effects on foraminal dimension are small and directionally mixed, and the literature is heterogeneous in device, posture, loading method, and outcome measure. Standing weight-bearing cone-beam CT provides three-dimensional isotropic imaging of the osseous foraminal boundary under physiological load, permitting quantitative cross-sectional area measurement in neutral and extension within a single session. Soft-tissue contrast is limited relative to MRI, which is why all primary measurements in this protocol are bony-boundary geometric measures. To our knowledge, no previous study has evaluated standing lumbar weight-bearing CT against a prospectively standardized, blinded, pre-imaging clinical phenotype. This study estimates that concordance, estimates whether it differs between neutral and standing extension, and characterizes the magnitude of positional change in foraminal dimension.

Tipo de estudio

De observación

Inscripción (Estimado)

90

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Jessica Lee, PhD
  • Número de teléfono: 913-574-0958
  • Correo electrónico: jlee33@kumc.edu

Ubicaciones de estudio

    • Kansas
      • Kansas City, Kansas, Estados Unidos, 66160
        • University of Kansas Medical Center
        • Contacto:
          • Jessica Lee, PhD
          • Número de teléfono: 913-574-0958
          • Correo electrónico: jlee33@kumc.edu
        • Investigador principal:
          • Neil Segal, MD,MS

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

45 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Adults with lumbar radicular symptoms (unilateral or bilateral with clear unilateral dominance) identified from PM&R spine clinic and affiliated clinics at KUMC.

Descripción

Inclusion Criteria:

  • Age ≥45 years.
  • Predominant unilateral lumbar radicular pain and/or paresthesias. True bilateral radicular presentations are excluded.
  • Lumbar radicular pattern on chart-review screening - a coarse eligibility filter only. Root level is not assigned at screening; it is assigned by the blinded standardized examination after enrollment (§8).
  • Ability to stand unsupported to undergo study examination and WBCT.
  • Informed consent, including broad re-contact consent and consent to outcomes follow-up.

Exclusion Criteria:

A candidate meeting any of the following is excluded:

  1. True bilateral or symmetric radicular presentation with no dominant symptomatic side. The side-contrast endpoint (§10.3) requires an asymptomatic homolog. Unilaterally dominant presentations with minor contralateral involvement are eligible; isolated laterality is recorded and drives a clean-unilateral sensitivity analysis.
  2. Radicular symptoms attributable to a non-degenerative cause - neoplasm, infection, inflammatory or autoimmune disease, acute fracture, or other non-degenerative structural lesion at the symptomatic level.
  3. Any prior lumbar spine surgery - instrumented fusion, posterior instrumentation, decompression, or discectomy. Altered biomechanics, junctional change, and retained/residual disc or epidural fibrosis distort foraminal and segmental anatomy and confound both measurement and symptom attribution.
  4. Any lumbar spine procedure in the last 12 weeks - including any epidural steroid injection, radiofrequency nerve ablation, facet injection, medial branch block or SI joint injection
  5. Inability to stand and hold the neutral and extension positions for acquisition with no more than light bilateral fingertip contact - from a balance disorder, orthostatic intolerance, lower-limb weakness, weight-bearing restriction, or pain that precludes positioning.
  6. Pregnancy or possibility of pregnancy. Screening and testing per institutional and RSO policy (§13).
  7. BMI > 35 kg/m2. Cone-beam image quality degrades with soft-tissue path length independently of dose, and osseous depiction becomes diagnostically unusable in the 32-35 range (Benz 2018). Because the primary endpoint is a bony-boundary geometric measurement, quality loss translates directly into measurement error. Set pre-emptively rather than by post-acquisition exclusion, which would irradiate participants whose acquisitions are predictably unusable.
  8. Inability to provide informed consent, or insufficient capacity to understand and communicate symptoms for the standardized phenotype examination (§8).

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: OTHER
  • Perspectivas temporales: CROSS_SECTIONAL

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Lumbar WBCT

Participants will be identified through chart-review screening. Eligible and enrolled participants will undergo a blinded, standardized clinical phenotype exam performed by an evaluator blinded to the chart-review call. The participant also will be asked to complete 4 participant-reported surveys (Oswestry Disability Index (ODI), pain numeric rating scale (NRS), patient-reported provocative posture, symptom duration). The participant then will undergo two WBCT scans, one in a neutral position and one in an extension position. These two scans will be performed in the same session.

Participants will undergo two WBCT scans, one in a neutral position and one in an extension position.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Comparison of neutral WBCT position to prespecified clinical phenotype
Periodo de tiempo: From enrollment to end of visit at 1 day

Estimate the proportion of participants in whom neutral standing WBCT demonstrates prespecified foraminal pathology at the side and root level assigned by the blinded, locked clinical phenotype

From enrollment to end of visit at 1 day

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Comparison of extension WBCT position to prespecified clinical phenotype
Periodo de tiempo: From enrollment to end of visit at 1 day

Extension secondary. Estimate the proportion of participants in whom spinal extension standing WBCT demonstrates prespecified foraminal pathology at the side and root level assigned by the blinded, locked clinical phenotype; to estimate the within-participant change in concordance between the neutral and extension acquisitions; and to estimate the within-participant side-contrast on each acquisition and its change between them.

From enrollment to end of visit at 1 day
Comparison of standing WBCT to supine MRI images
Periodo de tiempo: From enrollment to end of visit at 1 day

MRI secondary. In the MRI-available subset, compare standing WBCT and supine MRI concordance against the same clinical reference standard (paired; McNemar on discordant pairs).

From enrollment to end of visit at 1 day
Comparison of electrodiagnostic (EDX) testing in WBCT vs MRI
Periodo de tiempo: From enrollment to end of visit at 1 day

EDX secondary. In the EDX-available and EDX-positive subset, describe WBCT-EDX and MRI-EDX same-level same-side agreement.

From enrollment to end of visit at 1 day

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Neil Segal, MD,MS, University of Kansas Medical Center

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de noviembre de 2026

Finalización primaria (Estimado)

1 de noviembre de 2027

Finalización del estudio (Estimado)

1 de noviembre de 2027

Fechas de registro del estudio

Enviado por primera vez

10 de noviembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Publicado por primera vez (Actual)

17 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

INDECISO

Descripción del plan IPD

If deidentified IPD is requested, for example for a meta-analysis or other study requiring those data, the investigators would provide those data.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

producto fabricado y exportado desde los EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir